Emanuela Bartoccioni

2.4k total citations
43 papers, 1.6k citations indexed

About

Emanuela Bartoccioni is a scholar working on Neurology, Infectious Diseases and Oncology. According to data from OpenAlex, Emanuela Bartoccioni has authored 43 papers receiving a total of 1.6k indexed citations (citations by other indexed papers that have themselves been cited), including 32 papers in Neurology, 17 papers in Infectious Diseases and 8 papers in Oncology. Recurrent topics in Emanuela Bartoccioni's work include Myasthenia Gravis and Thymoma (31 papers), Peripheral Neuropathies and Disorders (24 papers) and Antifungal resistance and susceptibility (17 papers). Emanuela Bartoccioni is often cited by papers focused on Myasthenia Gravis and Thymoma (31 papers), Peripheral Neuropathies and Disorders (24 papers) and Antifungal resistance and susceptibility (17 papers). Emanuela Bartoccioni collaborates with scholars based in Italy, United States and Germany. Emanuela Bartoccioni's co-authors include Flavia Scuderi, Mariapaola Marino, Amelia Evoli, Carlo Provenzano, Amelia Evoli, P. Tonali, Giacomo Minicuci, Raffaele Iorio, Paolo Emilio Alboini and Valentina Damato and has published in prestigious journals such as PLoS ONE, Neurology and Annals of the New York Academy of Sciences.

In The Last Decade

Emanuela Bartoccioni

43 papers receiving 1.6k citations

Peers

Emanuela Bartoccioni
Matthew N. Meriggioli United States
Simon Rinaldi United Kingdom
Michel Toledano United States
J. L. Chason United States
Emanuela Bartoccioni
Citations per year, relative to Emanuela Bartoccioni Emanuela Bartoccioni (= 1×) peers Flavia Scuderi

Countries citing papers authored by Emanuela Bartoccioni

Since Specialization
Citations

This map shows the geographic impact of Emanuela Bartoccioni's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Emanuela Bartoccioni with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Emanuela Bartoccioni more than expected).

Fields of papers citing papers by Emanuela Bartoccioni

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Emanuela Bartoccioni. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Emanuela Bartoccioni. The network helps show where Emanuela Bartoccioni may publish in the future.

Co-authorship network of co-authors of Emanuela Bartoccioni

This figure shows the co-authorship network connecting the top 25 collaborators of Emanuela Bartoccioni. A scholar is included among the top collaborators of Emanuela Bartoccioni based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Emanuela Bartoccioni. Emanuela Bartoccioni is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
Andreetta, Francesca, Elena Rinaldi, Emanuela Bartoccioni, et al.. (2017). Diagnostics of myasthenic syndromes: detection of anti-AChR and anti-MuSK antibodies. Neurological Sciences. 38(S2). 253–257. 13 indexed citations
2.
Evoli, Amelia, Paolo Emilio Alboini, Raffaele Iorio, Valentina Damato, & Emanuela Bartoccioni. (2017). Pattern of ocular involvement in myasthenia gravis with MuSK antibodies. Journal of Neurology Neurosurgery & Psychiatry. 88(9). 761–763. 25 indexed citations
3.
Evoli, Amelia, Pietro Caliandro, Raffaele Iorio, et al.. (2015). Poly-autoimmunity in patients with myasthenia gravis: A single-center experience. Autoimmunity. 48(6). 412–417. 15 indexed citations
4.
Marino, Mariapaola, Flavia Scuderi, Chengyong Shen, et al.. (2015). Flow Cytofluorimetric Analysis of Anti-LRP4 (LDL Receptor-Related Protein 4) Autoantibodies in Italian Patients with Myasthenia Gravis. PLoS ONE. 10(8). e0135378–e0135378. 29 indexed citations
5.
Evoli, Amelia, Raffaele Iorio, & Emanuela Bartoccioni. (2015). Overcoming challenges in the diagnosis and treatment of myasthenia gravis. Expert Review of Clinical Immunology. 12(2). 157–168. 13 indexed citations
6.
Marino, Mariapaola, Gabriele Di Sante, Flavia Scuderi, et al.. (2014). T cell repertoire in DQ5-positive MuSK-positive myasthenia gravis patients. Journal of Autoimmunity. 52. 113–121. 25 indexed citations
7.
Coppedè, Fabio, Roberta Ricciardi, Maria Denaro, et al.. (2013). Association of the DNMT3B -579G>T Polymorphism with Risk of Thymomas in Patients with Myasthenia Gravis. PLoS ONE. 8(11). e80846–e80846. 18 indexed citations
8.
Provenzano, Carlo, Roberta Ricciardi, Flavia Scuderi, et al.. (2011). PTPN22 and myasthenia gravis: Replication in an Italian population and meta-analysis of literature data. Neuromuscular Disorders. 22(2). 131–138. 16 indexed citations
9.
Marino, Mariapaola, Flavia Scuderi, Carlo Provenzano, & Emanuela Bartoccioni. (2010). Skeletal muscle cells: from local inflammatory response to active immunity. Gene Therapy. 18(2). 109–116. 61 indexed citations
10.
Provenzano, Carlo, Mariapaola Marino, Flavia Scuderi, Amelia Evoli, & Emanuela Bartoccioni. (2009). Anti-acetylcholinesterase antibodies associate with ocular myasthenia gravis. Journal of Neuroimmunology. 218(1-2). 102–106. 17 indexed citations
11.
Marino, Mariapaola, Flavia Scuderi, Carlo Provenzano, et al.. (2008). IL-6 regulates MCP-1, ICAM-1 and IL-6 expression in human myoblasts. Journal of Neuroimmunology. 196(1-2). 41–48. 32 indexed citations
12.
Padua, Luca, P. Tonali, Irene Aprile, et al.. (2006). Seronegative myasthenia gravis: comparison of neurophysiological picture in MuSK+ and MuSK− patients. European Journal of Neurology. 13(3). 273–276. 50 indexed citations
13.
Marino, Mariapaola, et al.. (2003). TGF-β1 and IL-10 modulate IL-1β-induced membrane and soluble ICAM-1 in human myoblasts. Journal of Neuroimmunology. 134(1-2). 151–157. 19 indexed citations
14.
Bartoccioni, Emanuela, Mariapaola Marino, Amelia Evoli, et al.. (2003). Identification of Disease‐Specific Autoantibodies in Seronegative Myasthenia Gravis. Annals of the New York Academy of Sciences. 998(1). 356–358. 2 indexed citations
15.
Scuderi, Flavia, Mariapaola Marino, Lucrezia Colonna, et al.. (2002). Anti-P110 Autoantibodies Identify a Subtype of “Seronegative” Myasthenia Gravis with Prominent Oculobulbar Involvement. Laboratory Investigation. 82(9). 1139–1146. 78 indexed citations
16.
Marino, Mariapaola, et al.. (2001). Constitutive and cytokine-induced expression of MHC and intercellular adhesion molecule-1 (ICAM-1) on human myoblasts. Journal of Neuroimmunology. 116(1). 94–101. 35 indexed citations
17.
Mazzarelli, Paola, et al.. (1998). Effect of transforming growth factor-β1 on interleukin-6 secretion in human myoblasts. Journal of Neuroimmunology. 87(1-2). 185–188. 18 indexed citations
18.
Skeie, Geir, Emanuela Bartoccioni, Amelia Evoli, Johan A. Aarli, & Nils Erik Gilhus. (1996). Ryanodine receptor antibodies are associated with severe myasthenia gravis. European Journal of Neurology. 3(2). 136–140. 18 indexed citations
19.
Battaglia, Federica, Giovanni Scambia, Carlo Provenzano, et al.. (1988). Receptor for Epidermal Growth Factor in Neoplastic and Non‐Neoplastic Human Thymus. Annals of the New York Academy of Sciences. 551(1). 366–368. 1 indexed citations
20.
Savino, Wilson, Emanuela Bartoccioni, F. Homo‐Delarche, et al.. (1988). Thymic hormone containing cells—IX. Steroids in vitro modulate thymulin secretion by human and murine thymic epithelial cells. Journal of Steroid Biochemistry. 30(1-6). 479–484. 44 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Rankless by CCL
2026